Related Experiment Video

Updated: May 18, 2026

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of

Uma Raju1, Oliver Riesterer, Zhi-Qiang Wang

  • 1University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. uraju@mdanderson.org

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|September 27, 2012
PubMed
Abstract

Insights

Dasatinib enhances radiotherapy for head and neck cancer by inducing apoptosis and blocking DNA repair in epidermal growth factor receptor-expressing cells. This targeted approach shows promise for improving patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy

Background:

  • Epidermal growth factor receptor (EGFR) signaling inhibition improves outcomes in head and neck cancer but novel strategies are needed.
  • EGFR interacts with c-Src kinases, suggesting a potential therapeutic target.

Purpose of the Study:

  • Investigate dasatinib, a c-Src kinase inhibitor, for enhancing radiosensitivity in human head and neck squamous cell carcinomas (HNSCC).
  • Examine the mechanisms by which dasatinib affects HNSCC radiosensitivity.

Main Methods:

  • Six HNSCC cell lines were treated with dasatinib and/or radiation.
  • Assessed cell survival, colony formation, apoptosis, cell cycle, and DNA repair markers (EGFR, γ-H2AX, 53BP1).
  • Analyzed protein interactions and signaling pathways using immunoprecipitation and Western blots; c-Src was suppressed using siRNA.

Main Results:

  • Dasatinib suppressed survival in all HNSCC lines and enhanced radiosensitivity in EGFR-expressing lines (HN-5, MDA-183).
  • In HN-5 cells, dasatinib inhibited c-Src phosphorylation, decreased DNA repair, and interfered with EGFR nuclear localization and DNA-PKcs association.
  • Suppression of c-Src partially increased radiosensitivity in HN-5 cells.

Conclusions:

  • Dasatinib induces apoptosis and inhibits DNA repair in EGFR-expressing HNSCC cells, improving radiotherapy outcomes.
  • Further in vivo studies are warranted for potential clinical translation.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...